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The Rai-Congrescentrum, Amsterdam, May 13, 1985 
WILLIAM J. CuNLIFFE, SECRETARY 
Present: A maximum of 61 attended the meeting (not all were 
present at the beginning and not all stayed to the end). The 
minimum number of attendees was 45. 
Presidential Address 
Dr. A. Giannetti reported that the Board had been very 
active in the past twelve months. Considerable thought and 
action had been put into improving the status and success of 
our meetings. All these items were to be discussed subsequently 
in the AGM. Important items included the need for our own 
journal?, central themes, programme advisory panels, poster 
discussion and postgraduate education. 
Minutes of the Last General Assembly 
These were approved without dissent. 
Report of the Treasurer 
B. J. Vermeer reported that the financial status of the ESDR 
continued to improve. The credit balance as of January 1, 1985 
was 57,681 Dutch guilders and in the savings account there was 
55,000 guilders, making a total of 112,681 guilders. On the 
credit side, the Dutch government kindly contributed 18,130 
gui lders for t he 1984 meeting and the income from participants 
for that meeting was 40,722 guilders. At this present meeting 
there was less support from industry. There are several reasons 
for this: the ESDR is not particularly clinically oriented: the 
Society has often met in Holland and clearly this is a drain on 
local drug companies and there is a limit to the amount of 
money t hey can provide for supporting such meetings. In the 
question time R. Marks wondered if we could get a better 
interest rate on the savings account. Our thanks are due to B. 
J . Vermeer. 
Report of the Programme Committee (P. Fritsch, Chairman, B. 
Czarnetzki , J-P. Ortonne, A.J. Thody) 
P . Fritsch put to the meeting four proposals for discussion: 
central themes, poster discussion, special advisors and the 
number of papers accepted. 
Historically the central theme was suggested by Dr. Fusenig, 
and since t hen we have had three central themes: inflammatory 
mediators, monoclonal antibodies and receptors. The members, 
with two abstentions, were against the central theme although 
G. Sting! suggested that the titles of the guest lectures could 
somehow be related as a type of central theme. 
Discussion as to whether or not there should be po.<;ter 
discussion was long. There was no very clear cut opinion. 
Suggestions that could be considered by the Programme Com-
mittee were a plenary session for discussion of those posters 
which achieved the highest score. Apparently poster discussions 
seem to work well in Germany but in some countries such as 
England there isn't too much enthusiasm for them. K. T. 
Holland suggested that there should be a vote. 28 were in favour 
of no poster discussion and 26 were in favour; there were 3 
abstentions. 
For many years there has been considerable controversy 
about the selection of papers. Dr. Fritsch explained that t his 
year the Programme Committee used an advisory panel for 
guidance. With only a few exceptions there was reasonable 
agreement between the Programme Committee and the advi-
sory panel. However, where there was a discrepancy the expert 
advice proved to be of help. Peter Fritsch presented to the 
members a list of advisors who would possibly advise over a 
four year period. R. Marks commented that there were some 
obvious exceptions. This was confirmed by others and so it was 
suggested to the secretary that suggestions for advisors should 
be forwarded in writing to P. Fritsch. He would then put 
together a final list. There was an overwhelming vote to support 
the idea of an advisory panel. 
The debate on the number of papers which should be accepted 
probably aroused the greatest debate in this section of the 
meeting. Feelings were strong for most alternatives, such as to 
accept only the minimum of papers; for plenary sessions only; 
plenary sessions plus two or more concurrent sessions. If there 
were concurrent sessions it was agreed that perhaps more time 
for discussion would be helpful. If concurrent sessions were 
held strict timing of the parallel sessions was essential. Ob-
viously with such a wide range of likes and dislikes it was felt 
that the Board must choose the programme according to the 
physical circumstances in which the meeting was held and the 
quality of abstracts received. 
Postgraduate Education 
J. Ring reported that the Board were anxious to improve the 
general postgraduate education, both for basic scientists and 
clinicians. He explained that in the next and, hopefully, sub-
sequent meetings we would have on the first day of the meeting 
a session of about four hours in which invited experts would 
give an in depth talk on their special subject. The experts would 
often be from the ESDR but, for example, at the next joint 
meeting would include members of the SID as well as university 
colleagues from Geneva. The aim of these meetings would be 
to give new and old members an update on that particular 
subject. This suggestion was accepted unanimously. 
Report of the Editor of The Journal of Investigative 
Dermatology 
Dr. Howard Baden, the Editor of the JID, expressed his 
pleasure to be attending the meeting and gave his report. 
Dr. Baden was delighted to report that the Journal is healthy 
and experiencing a burst of growth as reflected by the increased 
number of received manuscripts. The ramifications of this 
growth are complex. Not only is the workload of the editors 
significantly increased, but it puts the editor in the very uncom-
fortable position of choosing which papers of very similar 
quality are to be published. This is not good for the academic 
dermatologic community at a time when grants are hard to 
come by and publication in respected journals such as ours is 
important. Dr. Baden's management team are actively involved 
in negotiations to try and remedy the situation and some of 
these may involve increased costs of publishing papers as well 
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as increased dues. The time from submission to publication is 
increasing above the 6 month figure of last year. This is in part 
due to our even more stringent review process to be certain 
that we are making t he best choice in accepting papers. How-
ever some reviewers hold on to papers too long despite an 
aggressive approach-by letters and phone calls. 
Dr. Baden discussed the editorials primarily directed to call-
ing attention to new areas of biomedical research, which have 
been based on a particular article in that issue. These articles 
do take up pages, but many Journals have picked up on this 
and the editorial board has felt they contribute significantly. 
They a lso reach out to our loyal members whose strengths are 
not in hard science but are interested in being informed. 
Dr. Baden stressed again t he need for reviewers on all topics. 
Although he has had some volunteers as a result of our pub-
lished notices they are too few. Senior investigators and heads 
of departments are not cooperating in identifying on a current 
basis those individua ls in their groups who could help. It is 
difficult for the editors to identify from a list of authors on a 
paper those individuals who are potential reviewers for other 
papers. 919 reviewers had been used in 1984-646 from North 
America, 223 from Europe and 50 elsewhere. 
The number and distribution of manuscripts received in 1984 
is shown in the table. This is almost 100 new manuscripts 
above last year and based on our month by month monitoring 
of received manuscripts t here could be an additional increase 
of as much as 150 in 1985 
Submitted 4 70 
Accepted 190 
Rejected 217 
In revision 52 
Withdrawn 4 
Out for review 4 
On hold 3 
A somewhat greater number of papers from Europe have 
been received. Among other things this indicates support by 
our colleagues in Europe as well as t heir willingness to pay 
page charges even with t heir more difficult financial situation 
relative to the dollar. Although the percent of accepted papers 
from Europe is lower than that from North America, many of 
the papers identified as coming from North Ameria (because of 
first authorship) have E uropean collaborators and the percent 
of European papers on which a final decision has not been 
made is relatively higher which means the percent of accepted 
papers appears artificially lower. 
In 1984 there were 1123 pages which is almost exactly the 
1125 a llocated in our contract. The number of published man-
uscripts was up a few to 197, higher t han in any previous year. 
Dr- Baden felt that we must increase the number of available 
pages by perhaps 100 to meet the increasing number of good 
papers we are receiving. 
Over t he past several months Dr. Baden has been negotiating 
with Elsevier, who appear to be an excellent publishing house 
who clearly have a lot to offer t he JID. A contract has been 
formulated and if acceptable by the SID must be signed on July 
1, 1985 so t hat publishing of the JID by Elsevier could start on 
January 1, 1986. 
After H. Baden's report the secreta ry stated that the Board 
had been discussing at the last two Board meetings whether or 
not we should have our own journal. The Board is spli t with 
this decision. Comments from the t1oor also were at variance 
although most people, in particular G. Sting! and Ch. Lapiere, 
spoke out in favour of keeping in with the JID. Others, such as 
T. Krieg, gave reasons why a new European journal may be of 
benefit. Members obviously much appreciated the problems of 
starting a new journal, in particular the cost and need fo r an 
editor who had the time and finances to carry out such a job 
successfully. 
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Comments included the possibility of the JID having more 
pages, the possibility somehow of the Europeans having a 
greater say in the management of the JID, but as the journal 
is an official item of the SID the impossibilities a lmost of the 
suggestion were realised. At a vote most found for the time 
being that the ESDR continued to support the JID (29 for, 11 
against and 7 abstentions). 
Clearly this problem is a very important issue and it would 
be unrealistic to leave the problem without further discussion 
for several reasons, e.g. Greaves and Schaefer are reported to 
be interested in forming a dermatopharmacology journal but 
wish to leave their decision until the ESDR had decided 
whether or not it should have its own journal. Furthermore, 
t he SID are planning a new contract with Elsevier and since 
we are partners but not contractually so, then Dr. Baden is 
keen to know our definitive decisions. It was suggested by 
Plewig t hat if we were truly a partner of the SID with the JID 
t hen we ought to see the contract and get legal advice. However, 
on close reading of the contract (which we only received the 
day before the Annual General Meeting) it is very clear that 
we are not in any way (except academically) linked with the 
JID and so legal advice is unnecessary. T he secretary stated 
that as a result of t he uncertainty on this item the Board would 
have an extra board meeting the following day. The Board did 
in fact meet the next day and their decision was as follows: 
(a) To stress to Dr. Baden that they were pleased with the 
way that he had scientifically and managerially run the JID. 
(b) That we would continue to support the JID and wish to 
have our logo still with the JID. 
(c) That as a result of the uncertainty about the need for a 
new journal or to stay with the JID the Board has formed a 
sub-committee who will write to previous Presidents, Secre-
taries and Treasurers of the Society with a detailed question-
naire for their answers and additional comments. It is clear 
t hat t he question of t he possibility of a new journal for the 
Society will be an important event during the next twelve 
months or so, and the Secretary very much would appreciate 
written comments from members on this item. 
Report of the Secretary 
The membership of t he Society has increased to 481. There 
has a lso been an increase of six supporting members, making a 
total of 37. The number of people who attended the 1985 
meeting was 281. This is 13 more than the previous meeting. 
The Board has discussed our links with other societies and 
have decided that the ESDR will have no official attachment 
to the International Congress of Dermatology in 1987. In his 
Presidential addres Dr. Giannetti reported that he had looked 
into the possiblity of us linking with the European Molecular 
Biological Organisation with a view to obtain ing high quality 
guest speakers who could also participate in workshops. Appar-
ently there would be a chance of obtaining financial support 
(from EMBO) fo r attracting such eminent speakers to our 
Society. 
The Secretary thanked Drs. H. Hi:in igsmann and G. Sting! 
for organising what was an excellent meeting in Baden on 
Photomedicine, February 9-10, 1985. He also commented that 
he looked forward to and hoped that many members would 
attend the clinically oriented symposium on Genetics in Der-
matology in Oslo, February 7- 8, 1986 organised by Dr. T . 
Gedde-Dahl Jr., Norsk Hydro's Institute for Cancer Research, 
The Norwegian Radium Hospital, 010 Oslo 3, Norway and 
Professor P. Thune, Department of Dermatology, Ullevaal 
Hospital, University of Oslo, 0407 Oslo 4, Norway. 
During the preparation of the present meeting Dr. Wood, 
who was involved in much of the proof reading, noticed the 
tremendous number of abbreviations that were used, e.g. there 
were nine abbreviations for monoclonal bodies, and I.F. can 
mean things such as intermediate filaments or immunofluores -
cence. The Board therefore proposed that Dr. Wood, if he was 
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willing, should take on the task of trying to standardise abbre-
viations, and t his he was willing to do. The Secretary also 
thought that t here was something to be gained by altering the 
abstract form; there will be a new abstract form for the next 
meeting and comments on the abstract form would also be 
appreciated. 
Report on Publication of the Clinically Oriented Symposium 
The Clinically Oriented Symposia have traditionally been 
published as proceedings. However, in the past it was up to the 
organiser to search for an appropriate publish er. Printing qual-
ity and costs varied considerably as did the time lag between 
the meeting and the appearance of the volumes. In order to 
maintain some continuity in these publications and to bring 
t he volumes into a more uniform format, the Board decided at 
last year's meeting to create a regular series of publications 
which could host the papers of t he Clinically Oriented Sym-
posia. At t he last General Assembly, Herbert Honigsmann was 
appoin ted series editor for the next few years and he was 
commissioned to find a suitable publisher for this purpose. 
Eight different publishing companies were approached and, 
finally, a contract was made with Karger AG, Basle, Switzer-
land. Karger offered t he best conditions and, moreover, pro-
vides for very high print ing standards. 
The contents of t he contract are summarised as follows: 
1. The ESDR will not be financially involved. 
2. Karger AG will publish the Clinically Oriented Symposia 
in the fo rmat of t he "Current Problems in Dermatology" but it 
will be indicated that this is now an official publication of the 
ESDR. The number of pages allotted per volume is 250. 
3. It is planned to organize this and all other forthcoming 
volumes in the format of reference books for a special topic and 
not as congress proceedings. 
4. For members of the ESDR and for attenders of a particular 
meeting a discount of 40% from the selling price will be granted. 
In addi tion, a 40% discount is offered for the subscription to 
"Dermatologica" (now edited by J-H Saurat). 
5. The series edi to r will be Herbert Honigsmann who has to 
coordinate with the volume editor(s). The volume editor will 
be the organi zers of the respective symposia and/or other 
subjects appointed by the organizers. 
Vol. 85, No. 5 
6. The ESDR is granted a royalty of 5% on the net price 
from the 80lst copy sold onwards. 
The first volume of the new series "Therapeutic Photo-
medicine" is already in press and is expected to be on t he 
market at the end of 1985. 
Appointment of N ew Members 
28 Applications were considered and accepted by the Society 
(21 active and 7 supporting). There had been two resignations. 
Appointment of M embers of the Board 
The President reported that the following members were due 
to retire after three years of service: W. J . Cunliffe, P. Fritsch, 
J . Kavonen and J-H Saurat. The re-election of the following 
active members was recommended by the Board: W. J. Cunliffe, 
P. Fritsch, J. Karvonen and J-H Saurat. Dr. A Giannetti 
resigned after six years on the Board and Dr. M. G. Bernengo 
was recommended. The General Assembly approved the nom-
inations without dissent. 
Place and Date of the 1986 Annual Meeting 
The 5th joint meeting of the ESDR and the SID will be held 
at the International Conference Centre of Geneva, Switzerland, 
June 22-26. 
Place and Date of the 1987 Annual Meeting 
The 16th Annual Meeting of the ESDR will be held at the 
Rai-Congrescentrum, Amsterdam, March 29-Aprill. 
Officers of the Board 
The President informed the membership of the following ap-
pointments: J-H Saurat, President; W. J. Cunliffe, Secretary 
and B. J . Vermeer, Treasurer. The Programme Committee: P. 
Fritsch (Chairman), B. Czarnetzki, J-P Ortonne and A. J. 
Thody. 
Any Other Business 
There was no further business, and Dr. Giannetti expressed 
on behalf of the members his thanks and gratitude to the 
secretariat and to the members of the Board for their service 
to the Society during their term of office. 
